Pharmacokinetics and Safety of DS-8500a, an Antidiabetic Drug, in Japanese Subjects with Hepatic or Renal Impairment: A Single-Center, Open-Label, Single-Dose Study

2018 ◽  
Vol 35 (8) ◽  
pp. 1239-1250 ◽  
Author(s):  
Manabu Kato ◽  
Hitoshi Ishizuka ◽  
Takashi Taguchi ◽  
Kazuhito Shiosakai ◽  
Emi Kamiyama ◽  
...  
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Single Center ◽  
Antidiabetic Drug ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study ◽  
Japanese Subjects

scholarly journals Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study

2016 ◽  
Vol 42 (3) ◽  
pp. 461-469 ◽  
Author(s):  
Sabrina Wiebe ◽  
David Schnell ◽  
Raimund Külzer ◽  
Dietmar Gansser ◽  
Anne Weber ◽  
...  
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study

An Open-label, Single-dose Study to Evaluate the Pharmacokinetic Variables of Edaravone in Subjects with Mild, Moderate, or No Renal Impairment

2020 ◽  
Vol 42 (9) ◽  
pp. 1699-1714
Author(s):  
Yoshinobu Nakamaru ◽  
Masae Kakubari ◽  
Kaori Yoshida ◽  
Makoto Akimoto ◽  
Kazuoki Kondo
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study

1027-P: A Phase 1, Open-Label, Single-Dose Study to Evaluate Pharmacokinetics of MEDI0382 in Patients with Renal Impairment

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1027-P
Author(s):  
GERNOT K. KLEIN ◽  
MARCELLA PETRONE ◽  
YE YANG ◽  
THUONG HOANG ◽  
SHEILA DICOSTANZA ◽  
...  
Keyword(s):  
Single Dose ◽  
Renal Impairment ◽  
Phase 1 ◽  
Open Label ◽  
Single Dose Study ◽  
Dose Study
Sign in / Sign up

Export Citation Format

Share Document